Skip to content

Meet SOHO France Young Investigator Syrine Bel Haj Yahia
Drs. DiPersio and Scheinberg at SOHO Central Europe
FDA grants Break Through Designation to enzomenib for relapsed or refactory acute leukemia
Hematologic oncology researchers persevere under shadow of unpredictable federal funding
Fixed-duration zanubrutinib, bendamustine, rituximab achieves high response rates for Waldenström macroglobulinemia in first report from phase 2 trial

Insider Reader Survey

Join SOHO

Insider Podcast
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
Meeting News
Multimedia
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Mantle Cell Lymphoma

Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda

Trending now Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma News

FDA clears IND application for CD19/CD20 dual-targeting in vivo CAR-T therapy LB2501

by SOHO Insider Editors
October 15, 2026
0 Comments

Lymphoma Mantle Cell Lymphoma News

China NMPA grants accelerated approval to rocbrutinib in relapsed or refractory mantle cell lymphoma

by SOHO Insider Editors
June 28, 2026
0 Comments

Lymphoma Indolent B-Cell Lymphomas Mantle Cell Lymphoma News

FDA grants orphan drug designation to EO2463 to treat indolent non-Hodgkin lymphoma

by SOHO Insider Editors
May 28, 2026
0 Comments

Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope

Mantle Cell Lymphoma News

Can PFS predict treatment-related overall survival in MCL?

by Kerri Fitzgerald
May 20, 2026
0 Comments

Lymphoma Mantle Cell Lymphoma

FDA grants accelerated approval to sonrotoclax for relapsed or refractory mantle cell lymphoma

by Leah Sherwood
May 13, 2026
0 Comments

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma SOHO 2026 News Society Updates

Submit an abstract for SOHO 2026 by May 15

by Leah Sherwood
May 9, 2026
0 Comments

Community Oncology News Community Oncology Lymphoma Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Video Interviews

Watch: Dr. Krish Patel on building partnerships between community and academic centers

by Leah Sherwood
April 22, 2026
0 Comments

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma SOHO 2026 Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms Society Updates

Registration now open for SOHO 2026

by SOHO Insider Editors
March 31, 2026
0 Comments

Lymphoma Mantle Cell Lymphoma SOHO 2025 Lymphoma News SOHO Insider Podcast

Drs. Melody, Phillips talk glofitamab in MCL

by Leah Sherwood
January 30, 2026
0 Comments

Lymphoma Mantle Cell Lymphoma News

US FDA grants priority review to sonrotoclax in relapsed or refractory MCL

by SOHO Insider Editors
December 5, 2025
0 Comments

1
2